Thus, the goal of the present review was to systematically review the published empirical literature and qualitatively synthesize existing evidence that either pharmacological or genetic manipulation/variation of FAAH, MAGL, and DAGL might impact obesity-related outcomes. Here, FAAH is linked to obesity disorder.